600 reports of this reaction
1.6% of all PHENYTOIN reports
#11 most reported adverse reaction
DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS is the #11 most commonly reported adverse reaction for PHENYTOIN, manufactured by Viatris Specialty LLC. There are 600 FDA adverse event reports linking PHENYTOIN to DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS. This represents approximately 1.6% of all 36,996 adverse event reports for this drug.
Patients taking PHENYTOIN who experience drug reaction with eosinophilia and systemic symptoms should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS is a less commonly reported adverse event for PHENYTOIN, but still significant enough to appear in the safety profile.
In addition to drug reaction with eosinophilia and systemic symptoms, the following adverse reactions have been reported for PHENYTOIN:
The following drugs have also been linked to drug reaction with eosinophilia and systemic symptoms in FDA adverse event reports:
DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS has been reported as an adverse event in 600 FDA reports for PHENYTOIN. This does not prove causation, but indicates an association observed in post-market surveillance data.
DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS accounts for approximately 1.6% of all adverse event reports for PHENYTOIN, making it a notable side effect.
If you experience drug reaction with eosinophilia and systemic symptoms while taking PHENYTOIN, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.